{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:26:06Z","timestamp":1745994366189},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"DOI":"10.7759\/cureus.10208","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:18:51Z","timestamp":1599077931000},"source":"Crossref","is-referenced-by-count":1,"title":["Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barr\u00e9 Syndrome and Influenza Vaccine \u2013 Up to Date Literature Review"],"prefix":"10.7759","author":[{"given":"Ravi","family":"Soni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey E","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwayne A","family":"Wiltshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilmaben S","family":"Vahora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi C","year":"2014","unstructured":"Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014, 58:1149-55. 10.1093\/cid\/ciu005","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13181","article-title":"Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed?","volume":"24","author":"Wachira VK","year":"2019","unstructured":"Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed?. Trop Med Int Health. 2019, 24:132-142. 10.1111\/tmi.13181","journal-title":"Trop Med Int Health"},{"key":"ref4","unstructured":"Guillain-Barr\u00e9 syndrome. (2019). Accessed. May21, 2020: https:\/\/www.cdc.gov\/campylobacter\/guillain-barre.html."},{"key":"ref5","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: current evidence","volume":"32","author":"Sanz Fadrique R","year":"2019","unstructured":"Sanz Fadrique R, Mart\u00edn Arias L, Molina-Guarneros JA, et al.. Guillain-Barr\u00e9 syndrome and influenza vaccines: current evidence. Rev Esp Quimioter. 2019, 32:288-295.","journal-title":"Rev Esp Quimioter"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws196","article-title":"Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise ME","year":"2012","unstructured":"Wise ME, Viray M, Sejvar JJ, et al.. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol. 2012, 175:1110-9. 10.1093\/aje\/kws196","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon DA","year":"2013","unstructured":"Salmon DA, Proschan M, Forshee R, et al.. Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013, 381:1461-8. 10.1016\/S0140-6736(12)62189-8","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020150","article-title":"Is an increased risk of developing Guillain-Barr\u00e9 syndrome associated with seasonal influenza vaccination? A systematic review and meta-analysis","volume":"8","author":"Petr\u00e1\u0161 M","year":"2020","unstructured":"Petr\u00e1\u0161 M, Lesn\u00e1 IK, D\u00e1\u0148ov\u00e1 J, et al.. Is an increased risk of developing Guillain-Barr\u00e9 syndrome associated with seasonal influenza vaccination? A systematic review and meta-analysis. Vaccines (Basel). 2020, 8:150. 10.3390\/vaccines8020150","journal-title":"Vaccines (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201961004","article-title":"Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017","volume":"61","author":"Gatt\u00e1s VL","year":"2018","unstructured":"Gatt\u00e1s VL, Braga PE, Koike ME, et al.. Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017. Rev Inst Med Trop Sao Paulo. 2018, 61:4. 10.1590\/S1678-9946201961004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.087","article-title":"Near real-time surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2010\/11 to 2013\/14","volume":"35","author":"Sandhu SK","year":"2017","unstructured":"Sandhu SK, Hua W, MaCurdy TE, et al.. Near real-time surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among the Medicare population, 2010\/11 to 2013\/14. Vaccine. 2017, 35:2986-2992. 10.1016\/j.vaccine.2017.03.087","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.07.019","article-title":"Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System","volume":"34","author":"Bardenheier BH","year":"2016","unstructured":"Bardenheier BH, Duderstadt SK, Engler RJ, et al.. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System. Vaccine. 2016, 34:4406-14. 10.1016\/j.vaccine.2016.07.019","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.048","article-title":"Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015","volume":"34","author":"Haber P","year":"2016","unstructured":"Haber P, Moro PL, Lewis P, et al.. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015. Vaccine. 2016, 34:2507-12. 10.1016\/j.vaccine.2016.03.048","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.045","article-title":"Surveillance for Guillain-Barr\u00e9 syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries","volume":"37","author":"Arya DP","year":"2019","unstructured":"Arya DP, Said MA, Izurieta HS, et al.. Surveillance for Guillain-Barr\u00e9 syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries. Vaccine. 2019, 37:6543-6549. 10.1016\/j.vaccine.2019.08.045","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.041","article-title":"Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season","volume":"37","author":"Perez-Vilar S","year":"2019","unstructured":"Perez-Vilar S, Wernecke M, Arya D, et al.. Surveillance for Guillain-Barr\u00e9 syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season. Vaccine. 2019, 37:3856-3865. 10.1016\/j.vaccine.2019.05.041","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.7.1154","article-title":"Clinical features of post-vaccination Guillain-Barr\u00e9 syndrome (GBS) in Korea","volume":"32","author":"Park YS","year":"2017","unstructured":"Park YS, Lee KJ, Kim SW, et al.. Clinical features of post-vaccination Guillain-Barr\u00e9 syndrome (GBS) in Korea. J Korean Med Sci. 2017, 32:1154-1159. 10.3346\/jkms.2017.32.7.1154","journal-title":"J Korean Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.080","article-title":"The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper","volume":"33","author":"Halsey NA","year":"2015","unstructured":"Halsey NA, Talaat KR, Greenbaum A, et al.. The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper. Vaccine. 2015, 33:5. 10.1016\/j.vaccine.2015.10.080","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis","volume":"33","author":"Mart\u00edn Arias LH","year":"2015","unstructured":"Mart\u00edn Arias LH, Sanz R, S\u00e1inz M, et al.. Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015, 33:3773-8. 10.1016\/j.vaccine.2015.05.013","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3908","article-title":"Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe","volume":"343","author":"Dieleman J","year":"2011","unstructured":"Dieleman J, Romio S, Johansen K, et al.. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011, 343:3908. 10.1136\/bmj.d3908","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0047-0","article-title":"Risk of Guillain-Barr\u00e9 syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study","volume":"31","author":"Ghaderi S","year":"2016","unstructured":"Ghaderi S, Gunnes N, Bakken IJ, et al.. Risk of Guillain-Barr\u00e9 syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Eur J Epidemiol. 2016, 31:67-72. 10.1007\/s10654-015-0047-0","journal-title":"Eur J Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7342","article-title":"Risk of Guillain-Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec","volume":"308","author":"De Wals P","year":"2012","unstructured":"De Wals P, Deceuninck G, Toth E, et al.. Risk of Guillain-Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec. JAMA. 2012, 308:175-81. 10.1001\/jama.2012.7342","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00768","article-title":"Guillain-Barre syndrome after trivalent influenza vaccination in adults","author":"Chang KH","year":"2019","unstructured":"Chang KH, Lyu RK, Lin WT, et al.. Guillain-Barre syndrome after trivalent influenza vaccination in adults. Front Neurol. 2019, 10.3389\/fneur.2019.00768","journal-title":"Front Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0598-z","article-title":"Guillain-Barr\u00e9 syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database","volume":"16","author":"Alcalde-Cabero E","year":"2016","unstructured":"Alcalde-Cabero E, Almaz\u00e1n-Isla J, Garc\u00eda L\u00f3pez FJ, et al.. Guillain-Barr\u00e9 syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database. BMC Neurol. 2016, 16:75. 10.1186\/s12883-016-0598-z","journal-title":"BMC Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd CN","year":"2013","unstructured":"Dodd CN, Romio SA, Black S, et al.. International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013, 31:4448-58. 10.1016\/j.vaccine.2013.06.032","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000903","article-title":"Canadian Immunization Monitoring Program Active. Guillain-Barr\u00c9 syndrome after immunization in Canadian children (1996-2012)","volume":"34","author":"Top KA","year":"2015","unstructured":"Top KA, Desai S, Moore D, et al.. Canadian Immunization Monitoring Program Active. Guillain-Barr\u00c9 syndrome after immunization in Canadian children (1996-2012). Pediatr Infect Dis J. 2015, 34:1411-3. 10.1097\/INF.0000000000000903","journal-title":"Pediatr Infect Dis J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.035","article-title":"Pandemic influenza A vaccination and incidence of Guillain-Barr\u00e9 syndrome in Korea","volume":"33","author":"Kim C","year":"2015","unstructured":"Kim C, Rhie S, Suh M, et al.. Pandemic influenza A vaccination and incidence of Guillain-Barr\u00e9 syndrome in Korea. Vaccine. 2015, 33:1815-23. 10.1016\/j.vaccine.2015.02.035","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082222","article-title":"Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe","author":"Silvana R","year":"2014","unstructured":"Silvana R, Weibel D, Dieleman JP, et al.. Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS ONE. 2014, 10.1371\/journal.pone.0082222","journal-title":"PLoS ONE"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3638","article-title":"Risk of Guillain-Barr\u00e9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany","volume":"23","author":"Prestel J","year":"2014","unstructured":"Prestel J, Volkers P, Mentzer D, et al.. Risk of Guillain-Barr\u00e9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014, 23:1192-204. 10.1002\/pds.3638","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt051","article-title":"Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010","volume":"178","author":"Polakowski LL","year":"2013","unstructured":"Polakowski LL, Sandhu SK, Martin DB, et al.. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Am J Epidemiol. 2013, 178:962-73. 10.1093\/aje\/kwt051","journal-title":"Am J Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2019-0028","article-title":"Influenza vaccination and Guillain-Barr\u00e9 syndrome: reality or fear","author":"Babazadeh A","year":"2019","unstructured":"Babazadeh A, Afshar ZM, Javanian M, et al.. Influenza vaccination and Guillain-Barr\u00e9 syndrome: reality or fear. J Transl Int Med. 2019, 10.2478\/jtim-2019-0028","journal-title":"J Transl Int Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz135","article-title":"Principal controversies in vaccine safety in the United States","volume":"69","author":"DeStefano F","year":"2019","unstructured":"DeStefano F, Bodenstab HM, Offit PA. Principal controversies in vaccine safety in the United States. Clin Infect Dis. 2019, 69:726-731. 10.1093\/cid\/ciz135","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35534-antigenic-variability-a-potential-factor-in-assessing-relationship-between-guillain-barr-syndrome-and-influenza-vaccine---up-to-date-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:13Z","timestamp":1707506533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35534-antigenic-variability-a-potential-factor-in-assessing-relationship-between-guillain-barr-syndrome-and-influenza-vaccine---up-to-date-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.10208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}